Small Cell Lung Cancer Extensive Stage trials recruiting in South Dakota

Fewer than 3 recruiting trials found.

All Small Cell Lung Cancer Extensive Stage trials nationally

Cities in South Dakota

Recruiting trials in South Dakota

• A Clinical Study of Gocatamig (MK-6070) and Infinatamab Deruxtecan (MK-2400) in People With Small Cell Lung Cancer (MK-6070-003)
  NCT07227597 · Phase: Phase 1, Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · South Dakota: Sioux Falls